UniProtKB/Swiss-Prot Q86XK2: Variant p.Lys715Asn

F-box only protein 11
Gene: FBXO11
Feedback?

Variant information Variant position:

715 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant:

LB/B The variants are classified into three categories: LP/P, LB/B and US.

LP/P: likely pathogenic or pathogenic.
LB/B: likely benign or benign.
US: uncertain significance

Residue change:

From Lysine (K) to Asparagine (N) at position 715 (K715N, p.Lys715Asn). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties:

Change from large size and basic (K) to medium size and polar (N) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score:

0 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

Lowest score: -4 (low probability of substitution).
Highest score: 11 (high probability of substitution).

More information can be found on the following page
Variant description:

Found in a patient with lymphoma; strongly diminishes ubiquitin-mediated degradation of BCL6. Any additional useful information about the variant.
Other resources:

Links to websites of interest for the variant.

Variant rs1572764737 [ dbSNP | Ensembl ]

Sequence information Variant position:

715 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length:

927 The length of the canonical sequence.
Location on the sequence:

GLGCIEDNEIFDNAMAGVWI K TDSNPTLRRNKIHDGRDGGI The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation:

The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         GLGCIEDNEIFDNAMAGVWIKTDSNPTLRRNKIHDGRDGGI

Mouse                         GLGCIEDNEIFDNAMAGVWIKTDSNPTLRRNKIHDGRDGGI

Rat                           GLGCIEDNEIFDNAMAGVWIKTDSNPTLRRNKIHDGRDGGI

Sequence annotation in neighborhood:

The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

Type: the type of sequence feature.
Positions: endpoints of the sequence feature.
Description: contains additional information about the feature.

Type	Positions	Description
Chain	1 – 927	F-box only protein 11
Repeat	694 – 716	PbH1 14
Alternative sequence	212 – 927	Missing. In isoform 4.
Alternative sequence	670 – 927	Missing. In isoform 3.

Literature citations
FBXO11 targets BCL6 for degradation and is inactivated in diffuse large B-cell lymphomas.
Duan S.; Cermak L.; Pagan J.K.; Rossi M.; Martinengo C.; di Celle P.F.; Chapuy B.; Shipp M.; Chiarle R.; Pagano M.;
Nature 481:90-93(2012)
Cited for: VARIANTS CYS-206; CYS-644; GLU-684; ASN-715 AND GLN-715; CHARACTERIZATION OF VARIANTS CYS-644; GLU-684; ASN-715 AND GLN-715; FUNCTION IN UBIQUITINATION OF BCL6; INTERACTION WITH BCL6; IDENTIFICATION IN THE SCF(FBXO11) COMPLEX; SUBCELLULAR LOCATION; INVOLVEMENT IN LYMPHOMA;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.